Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Total Current Liabilities (2016 - 2025)

Amicus Therapeutics filings provide 16 years of Total Current Liabilities readings, the most recent being $237.8 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 59.94% to $237.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $237.8 million, a 59.94% increase, with the full-year FY2025 number at $237.8 million, up 59.94% from a year prior.
  • Total Current Liabilities hit $237.8 million in Q4 2025 for Amicus Therapeutics, up from $198.9 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $237.8 million in Q4 2025 to a low of $99.7 million in Q1 2021.
  • Median Total Current Liabilities over the past 5 years was $155.5 million (2024), compared with a mean of $154.3 million.
  • Biggest five-year swings in Total Current Liabilities: fell 11.32% in 2024 and later surged 59.94% in 2025.
  • Amicus Therapeutics' Total Current Liabilities stood at $146.0 million in 2021, then dropped by 4.77% to $139.0 million in 2022, then rose by 20.62% to $167.7 million in 2023, then decreased by 11.32% to $148.7 million in 2024, then surged by 59.94% to $237.8 million in 2025.
  • The last three reported values for Total Current Liabilities were $237.8 million (Q4 2025), $198.9 million (Q3 2025), and $167.6 million (Q2 2025) per Business Quant data.